Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin T Low

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neuro-Oncology|July 22, 2025
Improvements in survival for glioblastoma in the post-Stupp protocol eraMackenzie Price, Justin T Low, Gordon Chavez, et al.
Neuro-Oncology Practice|November 17, 2022
Patterns of care in adult histone mutant gliomas: Results of an international surveyAlexander Yuile, Mustafa Khasraw, Justin T Low, et al.
F1000Research|November 3, 2022
cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade gliomaShashwat Tripathi, Hinda Najem, Akanksha Sanjay Mahajan, et al.
The Journal of Clinical Investigation|January 16, 2024
Understanding and therapeutically exploiting cGAS/STING signaling in glioblastomaJustin T Low, Michael C Brown, Zachary J Reitman, et al.
Neuro-Oncology Practice|March 18, 2024
Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant gliomaKatherine B Peters, Candice Alford, Amy Heltemes, et al.
Journal of Neuro-Oncology|November 5, 2025
Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade gliomaKavya Ramamurthy, Dina M Randazzo, Nicole Cort, et al.
Neuro-Oncology|January 10, 2026
SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use Alternative Lengthening of TelomeresAlexandrea Brown, Laura M Strickland, Elise N Erman, et al.
Cancer Cell|April 29, 2022
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibitionJustin T Low, Vidyalakshmi Chandramohan, Michelle L Bowie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral InfluenceMargaret Johnson, April Bell, Kristen L Lauing, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neuro-Oncology|July 22, 2025
Improvements in survival for glioblastoma in the post-Stupp protocol eraMackenzie Price, Justin T Low, Gordon Chavez, et al.
Neuro-Oncology Practice|November 17, 2022
Patterns of care in adult histone mutant gliomas: Results of an international surveyAlexander Yuile, Mustafa Khasraw, Justin T Low, et al.
F1000Research|November 3, 2022
cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade gliomaShashwat Tripathi, Hinda Najem, Akanksha Sanjay Mahajan, et al.
The Journal of Clinical Investigation|January 16, 2024
Understanding and therapeutically exploiting cGAS/STING signaling in glioblastomaJustin T Low, Michael C Brown, Zachary J Reitman, et al.
Neuro-Oncology Practice|March 18, 2024
Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant gliomaKatherine B Peters, Candice Alford, Amy Heltemes, et al.
Journal of Neuro-Oncology|November 5, 2025
Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade gliomaKavya Ramamurthy, Dina M Randazzo, Nicole Cort, et al.
Neuro-Oncology|January 10, 2026
SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use Alternative Lengthening of TelomeresAlexandrea Brown, Laura M Strickland, Elise N Erman, et al.
Cancer Cell|April 29, 2022
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibitionJustin T Low, Vidyalakshmi Chandramohan, Michelle L Bowie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral InfluenceMargaret Johnson, April Bell, Kristen L Lauing, et al.
Pageof 2